Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sabine Wächter, Franziska Knauff, Silvia Roth, Corinna Keber, Katharina Holzer, Jerena Manoharan, Elisabeth Maurer, Detlef K. Bartsch & Pietro Di Fazio. (2023) Synergic Induction of Autophagic Cell Death in Anaplastic Thyroid Carcinoma. Cancer Investigation 41:4, pages 405-421.
Read now
Read now
Lili Song, Shikai Liu & Sufen Zhao. (2022) Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway. Bioengineered 13:4, pages 11240-11257.
Read now
Read now
Gülen Gül, Dilek Ince, Nur Olgun & Erdener Ozer. (2022) PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance?. Fetal and Pediatric Pathology 41:1, pages 49-57.
Read now
Read now
Articles from other publishers (49)
Taned Chitapanarux, Pawut Gumrai, Sarawut Kongkarnka, Komson Wannasai & Nirush Lertprasertsuke. (2023) Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer. Scientific Reports 13:1.
Crossref
Crossref
Mengyuan Shi, Guo An, Nan Chen, Jinying Jia, Xinxin Cui, Tiancheng Zhan & Dengbo Ji. (2023) UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer. Cancers 15:9, pages 2502.
Crossref
Crossref
Vrushali Guhe, Prajakta Ingale, Anil Tambekar & Shailza Singh. (2023) Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Yong-Qiang Ao, Jian Gao, Shuai Wang, Jia-Hao Jiang, Jie Deng, Hai-Kun Wang, Bei Xu & Jian-Yong Ding. (2023) Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives. Molecular Cancer 22:1.
Crossref
Crossref
Györgyi Műzes & Ferenc Sipos. (2023) Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy. Biomedicines 11:4, pages 1130.
Crossref
Crossref
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Dimitris Matthaios & Michalis V. Karamouzis. (2023) Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment. Genes 14:2, pages 474.
Crossref
Crossref
Nader Aboul-Fettouh, Shelby L. Kubicki, Leon Chen, Sirunya Silapunt & Michael R. Migden. (2023) Targeted Therapy and Immunotherapy in Nonmelanoma Skin Cancer. Dermatologic Clinics 41:1, pages 23-37.
Crossref
Crossref
Ljubiša Jovanović, Andja Ćirković, Milena Jović & Radmila Janković. (2022) PD-L1 Expression in High-Grade Serous and Clear Cell Ovarian Cancer. Indian Journal of Gynecologic Oncology 20:4.
Crossref
Crossref
Faisal K. Alkholifi & Rana M. Alsaffar. (2022) Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer. Medicina 58:11, pages 1572.
Crossref
Crossref
Yuhe Lei, Enxin Zhang, Liangliang Bai & Yingjie Li. (2022) Autophagy in Cancer Immunotherapy. Cells 11:19, pages 2996.
Crossref
Crossref
Eglal Mahgoub, Jalal Taneera, Nabil Sulaiman & Maha Saber-Ayad. (2022) The role of autophagy in colorectal cancer: Impact on pathogenesis and implications in therapy. Frontiers in Medicine 9.
Crossref
Crossref
Xizhe Li, Ziyu Dai, Xianning Wu, Nan Zhang, Hao Zhang, Zeyu Wang, Xun Zhang, Xisong Liang, Peng Luo, Jian Zhang, Zaoqu Liu, Yanwu Zhou, Quan Cheng & Ruimin Chang. (2022) The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Ganesh G. DhakadSangita P. ShirsatKaveri P. Tambe. (2022) Review on Immuno-Oncology Agents for Cancer Therapy. Research Journal of Pharmacology and Pharmacodynamics, pages 47-52.
Crossref
Crossref
Ganesh G. DhakadSangita P. ShirsatKaveri P. TambeVinit KairnarRitik. S. Jain. (2022) Review on Immuno-Oncology agents for Cancer Therapy. Asian Journal of Pharmaceutical Research, pages 110-115.
Crossref
Crossref
Ismail Koyuncu, Ebru Temiz, Mustafa Durgun, Abdurrahim Kocyigit, Ozgur Yuksekdag & Claudiu T. Supuran. (2022) Intracellular pH-mediated induction of apoptosis in HeLa cells by a sulfonamide carbonic anhydrase inhibitor. International Journal of Biological Macromolecules 201, pages 37-46.
Crossref
Crossref
Grazia R. Tundo, Diego Sbardella, Francesco Oddone, Anna A. Kudriaeva, Pedro M. Lacal, Alexey A. BelogurovJr.Jr., Grazia Graziani & Stefano Marini. (2021) At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention. Cancers 13:19, pages 4852.
Crossref
Crossref
Candice Mckertish & Veysel Kayser. (2021) Advances and Limitations of Antibody Drug Conjugates for Cancer. Biomedicines 9:8, pages 872.
Crossref
Crossref
Sara Sannino, Megan E Yates, Mark E Schurdak, Steffi Oesterreich, Adrian V Lee, Peter Wipf & Jeffrey L Brodsky. (2021) Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised. eLife 10.
Crossref
Crossref
Amany Samir, Reda Tawab & Hend Eltayebi. (2021) Long non‑coding RNAs XIST and MALAT1 hijack the PD‑L1 regulatory signaling pathway in breast cancer subtypes. Oncology Letters 22:2.
Crossref
Crossref
Jawad Fares, Ilya Ulasov, Peter Timashev & Maciej S Lesniak. (2021) Emerging principles of brain immunology and immune checkpoint blockade in brain metastases. Brain 144:4, pages 1046-1066.
Crossref
Crossref
Ting Jiang, Xisha Chen, Xingcong Ren, Jin-Ming Yang & Yan Cheng. (2021) Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance. Drug Resistance Updates 56, pages 100752.
Crossref
Crossref
Felcia Lai, Bryson A. Hawkins, Esteban Cruz, Jane R. Hanrahan, Paul W. Groundwater & David E. Hibbs. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters
71
88
.
Hanna Javan, Farshid Dayyani & Nadine Abi-Jaoudeh. (2020) Therapy in Advanced Hepatocellular Carcinoma. Seminars in Interventional Radiology 37:05, pages 466-474.
Crossref
Crossref
Silvina Odete Bustos, Fernanda Antunes, Maria Cristina Rangel & Roger Chammas. (2020) Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy. Frontiers in Oncology 10.
Crossref
Crossref
Kevin Wong, James Nguyen, Lillie Blair, Marina Banjanin, Bunraj Grewal, Shane Bowman, Hailey Boyd, Grant Gerstner, Hyun Jun Cho, David Panfilov, Cho Ki Tam, Delaney Aguilar & Vishwanath Venketaraman. (2020) Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection. Journal of Clinical Medicine 9:11, pages 3575.
Crossref
Crossref
Alexander G. Raufi, Michael May, Richard A. Greendyk, Alina Iuga, Firas Ahmed, Mahesh Mansukhani & Gulam A. Manji. (2020) Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma. JCO Precision Oncology:4, pages 1006-1011.
Crossref
Crossref
V. Škuciová, S. Drahošová, D. Výbohová, V. Cígerová & M. Adamkov. (2020) The relationships between PD-L1 expression, CD8+ TILs and clinico-histomorphological parameters in malignant melanomas. Pathology - Research and Practice 216:9, pages 153071.
Crossref
Crossref
Jingwei Liu, Hao Li, Liping Sun, Yuan Yuan & Chengzhong Xing. (2020) Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival. BioMed Research International 2020, pages 1-11.
Crossref
Crossref
Deli Mao, Zhe Zhang, Xin Zhao & Xiaoqiang Dong. (2020) Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma. PeerJ 8, pages e8383.
Crossref
Crossref
云龙 张. (2020) Research Progress of Autophagy in Esophageal Squamous Cell Carcinoma. Advances in Clinical Medicine 10:10, pages 2323-2328.
Crossref
Crossref
Liliana Fernández-Trujillo, Juan E. Garcia-Robledo, Valeria Zúñiga-Restrepo & Luz F. Sua. (2020) Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series. Respiratory Medicine Case Reports 30, pages 101114.
Crossref
Crossref
Sreyashi Majumdar & Sudipto Saha. 2020. Systems and Synthetic Immunology. Systems and Synthetic Immunology
53
72
.
Joy Huang, Ashley Abing & Karen L. Reckamp. 2020. Oncology in the Precision Medicine Era. Oncology in the Precision Medicine Era
13
30
.
Maria L. Molina, David García-Bernal, Salvador Martinez & Rut Valdor. (2019) Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma. Cancers 12:1, pages 102.
Crossref
Crossref
Herman O. Sintim, Clinton G. Mikek, Modi Wang & Moloud A. Sooreshjani. (2019) Interrupting cyclic dinucleotide-cGAS–STING axis with small molecules. MedChemComm 10:12, pages 1999-2023.
Crossref
Crossref
Guan-Min Jiang, Yuan Tan, Hao Wang, Liang Peng, Hong-Tao Chen, Xiao-Jun Meng, Ling-Ling Li, Yan Liu, Wen-Fang Li & Hong Shan. (2019) The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Molecular Cancer 18:1.
Crossref
Crossref
Fan Feng, Moxuan Zhang, Chuanchao Yang, Xueyuan Heng & Xiujie Wu. (2019) The dual roles of autophagy in gliomagenesis and clinical therapy strategies based on autophagic regulation mechanisms. Biomedicine & Pharmacotherapy 120, pages 109441.
Crossref
Crossref
Shouping Xu, Shiyao Sui, Xianyu Zhang, Boran Pang, Lin Wan & Da Pang. (2019) Modulation of autophagy in human diseases strategies to foster strengths and circumvent weaknesses. Medicinal Research Reviews 39:5, pages 1953-1999.
Crossref
Crossref
Li Ma, Jialin Lv, Yujie Dong, Xinyong Zhang, Xi Li, Hui Zhang, Jingying Nong, Quan Zhang, Na Qin, Xinjie Yang, Jinghui Wang & Shucai Zhang. (2019) PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation. Interdisciplinary Sciences: Computational Life Sciences 11:2, pages 266-272.
Crossref
Crossref
Antonio Ieni, Roberta Cardia, Giuseppe Giuffrè, Luciana Rigoli, Rosario Alberto Caruso & Giovanni Tuccari. (2019) Immunohistochemical Expression of Autophagy-Related Proteins in Advanced Tubular Gastric Adenocarcinomas and Its Implications. Cancers 11:3, pages 389.
Crossref
Crossref
Grazia R. Tundo, Diego Sbardella, Pedro M. Lacal, Grazia Graziani & Stefano Marini. (2019) On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment. Chemotherapy 64:2, pages 62-80.
Crossref
Crossref
Hak Choy & Jameson Travis Mendel. 2019. Pulmonary Adenocarcinoma: Approaches to Treatment. Pulmonary Adenocarcinoma: Approaches to Treatment
57
86
.
Evangelos Koustas, Athanasios G. Papavassiliou & Michalis V. Karamouzis. (2018) The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status. PLOS ONE 13:11, pages e0207227.
Crossref
Crossref
David A. Gewirtz, Liliya Tyutyunyk-Massey & Joseph W. Landry. (2018) The potentially conflicting cell autonomous and cell non-autonomous functions of autophagy in mediating tumor response to cancer therapy. Biochemical Pharmacology 153, pages 46-50.
Crossref
Crossref
Yiting Wang, Huanbin Wang, Han Yao, Chushu Li, Jing-Yuan Fang & Jie Xu. (2018) Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion. Frontiers in Pharmacology 9.
Crossref
Crossref
David Díaz-Carballo, Sahitya Saka, Jacqueline Klein, Tobias Rennkamp, Ali H. Acikelli, Sascha Malak, Holger Jastrow, Gunther Wennemuth, Clemens Tempfer, Inge Schmitz, Andrea Tannapfel & Dirk Strumberg. (2018) A Distinct Oncogenerative Multinucleated Cancer Cell Serves as a Source of Stemness and Tumor Heterogeneity. Cancer Research 78:9, pages 2318-2331.
Crossref
Crossref
Jin Zhang, Guan Wang, Yuxin Zhou, Yi Chen, Liang Ouyang & Bo Liu. (2018) Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy. Cellular and Molecular Life Sciences 75:10, pages 1803-1826.
Crossref
Crossref
E. Jensen-Jarolim, H. J. Bax, R. Bianchini, S. Crescioli, T. R. Daniels-Wells, D. Dombrowicz, E. Fiebiger, H. J. Gould, S. Irshad, J. Janda, D. H. Josephs, F. Levi-Schaffer, L. O′Mahony, G. Pellizzari, M. L. Penichet, F. Redegeld, F. Roth-Walter, J. Singer, E. Untersmayr, L. Vangelista & S. N. Karagiannis. (2018) AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer. Allergy 73:2, pages 328-340.
Crossref
Crossref
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai & George G. Chen. (2017) New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, pages 564-570.
Crossref
Crossref